期刊
FUTURE ONCOLOGY
卷 15, 期 20, 页码 2413-2422出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2019-0024
关键词
chemoradiotherapy; chemotherapy; complication; esophageal neoplasms; meta-analysis; neoadjuvant; overall survival; pathological complete regression; progression-free survival; R0 resection rate
类别
资金
- Hebei Achievement of Clinical Translational Research in Tumor Field [162777114D]
Aim: To compare the clinical efficacy of neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant chemotherapy (nCT) for esophageal cancer. Methods: Randomized controlled trials reporting on the comparison of nCRT and nCT for esophageal cancer were identified. Results: Three eligible randomized controlled trials were identified and included with a total of 375 patients (189 nCRT, 186 nCT). Outcomes showed that compared with nCT group, R0 resection and pathologic complete response (pCR) rates were significantly increased in nCRT group. However, no significant difference was seen in 3- and 5-year progression-free survival or 3- and 5-year overall survival. Conclusion: The addition of radiotherapy to neoadjuvant chemotherapy results in higher R0 resection rate and pCR rate, without significantly impacting survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据